Posttraumatic growth and resilience among survivors of cancer in young adulthood in Switzerland: a report from the Adolescent and Young Adult (AYA) Psychosocial Health Study.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
Abstract originale
PurposeSurvivors of young adult cancer (YACS) face distinct psychosocial challenges. Posttraumatic growth (PTG) and resilience may aid adaptation, though their relationship and relevance in this age group remain insufficiently understood. We aimed to (1) describe PTG and resilience among Swiss YACS and (2) investigate the associations of PTG with resilience, sociodemographic, and cancer-related characteristics.MethodsWe included survivors aged 21-39 years at diagnosis, diagnosed at least two years prior. We conducted a questionnaire survey using the Posttraumatic Growth Inventory (PTGI; range:0-105) and the Connor-Davidson Resilience Scale (CD-RISC 10; range:0-40). Data were analyzed using descriptive statistics and linear regression.ResultsA total of 131 YACS (62% female; mean age at study = 37.6 years, SD = 5.1) were included. The PTG sum score was 54.6 (SD = 23.0, range:1-101), and YACS reported most PTG in Appreciation of life (mean = 3.3, 95% confidence interval: 3.2-3.6) and least in Spiritual change (1.1, 0.9-1.3). The mean resilience score was 28.06 (SD = 5.91, range:10-39), and YACS reported the highest score for the item "Achieving goals despite obstacles" (3.2, 2.6-3.0), and the lowest for the item "See humorous side of things" (2.1, 2.0-2.3). PTG was higher among females and those who received chemotherapy, while resilience showed no significant association with PTG.ConclusionThese findings suggest that PTG and resilience are distinct but complementary adaptation processes in YACS. With higher PTG linked to female gender and chemotherapy, and resilience showing no direct association with PTG, personalized psychosocial support remains essential to help survivors navigate their unique cancer experiences and promote well-being.
Parole chiave
Leggi il testo integrale originale
Testo estratto dalla pubblicazione: sono esclusi immagini, media, supplementi e parti soggette a diritti distinti.
Posttraumatic growth and resilience among survivors of cancer in young adulthood in Switzerland: a report from the Adolescent and Young Adult (AYA) Psychosocial Health Study
Abstract
Purpose
Survivors of young adult cancer (YACS) face distinct psychosocial challenges. Posttraumatic growth (PTG) and resilience may aid adaptation, though their relationship and relevance in this age group remain insufficiently understood. We aimed to (1) describe PTG and resilience among Swiss YACS and (2) investigate the associations of PTG with resilience, sociodemographic, and cancer-related characteristics.
Methods
We included survivors aged 21–39 years at diagnosis, diagnosed at least two years prior. We conducted a questionnaire survey using the Posttraumatic Growth Inventory (PTGI; range:0–105) and the Connor-Davidson Resilience Scale (CD-RISC 10; range:0–40). Data were analyzed using descriptive statistics and linear regression.
Results
A total of 131 YACS (62% female; mean age at study = 37.6 years, SD = 5.1) were included. The PTG sum score was 54.6 (SD = 23.0, range:1–101), and YACS reported most PTG in Appreciation of life (mean = 3.3, 95% confidence interval: 3.2–3.6) and least in Spiritual change (1.1, 0.9–1.3). The mean resilience score was 28.06 (SD = 5.91, range:10–39), and YACS reported the highest score for the item “Achieving goals despite obstacles” (3.2, 2.6–3.0), and the lowest for the item “See humorous side of things” (2.1, 2.0–2.3). PTG was higher among females and those who received chemotherapy, while resilience showed no significant association with PTG.
Conclusion
These findings suggest that PTG and resilience are distinct but complementary adaptation processes in YACS. With higher PTG linked to female gender and chemotherapy, and resilience showing no direct association with PTG, personalized psychosocial support remains essential to help survivors navigate their unique cancer experiences and promote well-being.
Supplementary Information
The online version contains supplementary material available at https://doi.org/10.1007/s00520-026-11383-6.
Keywords: Young adult cancer, Survivorship, Posttraumatic growth, Resilience
Background
Cancer in adolescents and young adults (AYAs; 15–39 years of age, although its upper boundary varies) differs from cancer in children or older adults in terms of tumor biology, distribution of cancer types, psychosocial needs, and late outcomes following treatment [1–4]. Thanks to better treatments, the 5-year survival rate increased to about 80% for AYAs diagnosed with cancer in Europe [5, 6]. As survival rates improve, the number of AYA cancer survivors continues to grow, and it has become increasingly recognized that they represent a distinct group requiring targeted efforts to improve their lives during and after treatment [7, 8]. These efforts are crucial, as many survivors continue to experience enduring physical and psychosocial consequences (so-called late effects) of their cancer diagnosis and treatment [9, 10]. As a result, many survivors might experience negative consequences, including a higher risk of cardiovascular diseases, endocrine disorders and mental health disorders, social isolation, and significant disruptions in education and career planning [9, 11–13].
Despite all the negative consequences of surviving cancer, literature has shown that dealing with a potentially traumatic event, such as getting diagnosed with cancer [14], might have a silver lining: people might “benefit” from the experience and report growth, such as more appreciation for life or intensified personal relationships [15–17]. Posttraumatic growth (PTG) describes a salutogenetic concept and a phenomenon in which individuals experience changes that surpass their pre-existing state after facing a burdensome experience [18]. In fact, it leads to growth and meaning-making in five domains of a person’s life: relating to others, new possibilities, personal strength, spiritual change, and appreciation of life [19]. A previous study in Swiss AYA cancer survivors aged 16 to 25 years at diagnosis has shown that all of the participants reported at least some PTG in the aftermath of cancer [20]. However, it did not cover the whole AYA age range up to 39 years.
Another salutogenic concept is resilience, describing the phenomenon of the level of adaptation when facing adversity, trauma, tragedy, threats, or significant sources of stress [21]. In contrast, posttraumatic growth does not refer to maintaining functioning during adversity, but to positive psychological changes that arise from struggling with traumatic experiences and life disruption [22]. It is debated as to whether or not PTG is a form of resilience, and whether or not growth is superior to resilience [23, 24]. A recent study described resilience as a relatively stable personality trait, rooted in dispositions such as optimism, emotional stability, and self-efficacy, which helps individuals cope with both everyday stress and traumatic experiences [25].In the present study, we follow the conceptualization of resilience as a stress-coping capacity that can be strengthened over time, as originally proposed by Connor and Davidson [26], which underlies both our use of the CD-RISC 10 and the interpretation of our findings.
Despite the often presented positive relationship between PTG and resilience in cancer patients and survivors, the strength of this association appears to vary across studies [27–30]. A recent study with AYA cancer survivors found a strong positive correlation between PTG and resilience, indicating that higher resilience was associated with higher levels of PTG in this population [30]. Similarly, Gündoğmuş et al. (2022) observed a positive relationship between resilience and PTG in breast cancer patients, emphasizing the role of resilience in facilitating coping and adjustment [28]. In another study, also with breast cancer patients, PTG was again positively associated with resilience, although it explained only 4% of the variance in the resilience scores, pointing to a weaker connection [29].
Although research on PTG and resilience in AYA cancer survivors remains limited, these constructs may play a key role in supporting their adjustment after cancer. This gap in age at diagnosis coverage, combined with inconsistent evidence on the PTG–resilience relationship in cancer survivors more broadly [27–30], underscores the need to clarify these constructs' interplay in a wider AYA cancer sample to inform differentiated, age-tailored psychosocial support. Understanding and fostering PTG and resilience in AYA cancer survivors is crucial to improving their long-term quality of life and ensuring they receive appropriate care if in need.
The proposed study aims to (1) describe PTG and resilience among Swiss survivors of young adult cancer (YACS) and (2) investigate the associations between PTG, sociodemographic and cancer-related characteristics, and resilience.
Methods
Sample and procedure
Study participants were recruited from hospitals in the German-speaking part of Switzerland. The clinics were identified with the support of Swiss cancer registries, from which we received lists of doctors who treat AYAs with cancer in Switzerland. These doctors were contacted and asked to collaborate by identifying former patients (YACS) and inviting them to participate in the current study. Survivors aged 21–39 at diagnosis were eligible, as survivors aged 15–20 at diagnosis were already covered by the Swiss Childhood Cancer Survivor Study (SCCSSS) [31]. They were German-speaking and were treated in Switzerland and diagnosed between 2010 and 2019, and survived for at least two years after their diagnosis. Between February 2023 and June 2024, AYA cancer survivors were sent a study package, including the cover letter, the study information, a consent form, the questionnaire, as well as a link for the online questionnaire, and a pre-paid return envelope. After 6 weeks, a reminder letter was sent to those who had not responded. All procedures performed in this study were in accordance with the ethical standards of the responsible research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The study was approved by the Ethics Committee Northwest and Central Switzerland (EKNZ 2022–01065, 12 October 2022).
Measurements
In total, the survey consisted of 185 items and was developed using a combination of standardized and self-developed questions regarding the survivors’ psychosocial health and needs, and their socio-demographic and cancer-related characteristics.
Posttraumatic growth
We assessed PTG using the German version of the Posttraumatic Growth Inventory (PTGI), which consists of 21 items and is well-validated [26]. It compromises five domains: Relating to others (7 items), New possibilities (5 items), Personal strength (4 items), Spiritual change (2 items), and Appreciation of life (3 items). Each item is rated using a 6-point Likert scale (0 = not at all to 5 = extremely). We calculated the mean for each of the five domains (possible range: 0–5) and the PTG sum score as the sum of all item scores (possible range: 0–105), with higher scores indicating higher levels of PTG. Based on previous publications, we categorized the answers into low (0,1), middle (2,3) and high (4,5) [16, 20] for descriptive purposes only while for the regression analyses, we used the continuous PTG sum score. We replaced missing PTG values with the mean of the respective domain if at least half of the items within that domain were available. Participants with insufficient valid responses in a subscale (i.e., less than half of the items) were excluded from that specific subscale analysis. Finally, we calculated the PTG mean score being the mean of all item scores (possible range: 0–5). Internal consistency of the PTGI in the present sample was excellent (Cronbach's α = 0.95).
Resilience
Resilience was assessed using the German version of the Connor-Davidson Resilience Scale (CD-RISC 10) consisting of 10 items [32]. It assesses various aspects of resilience, including Adapt to change, Can deal with whatever comes, Coping with stress strengthens, See humorous side of things, Tend to bounce back after illness or hardship, You can achieve your goals, Under pressure, focus and think clearly, Not easily discouraged by failure, Think of self as strong person, Can handle unpleasant feelings. Each item is rated using a 5-point Likert scale (0 = not at all true to 4 = almost always true). We categorized the answers into low (0,1), middle (2), and high (3,4) for descriptive purposes only, while the continuous score was used as predictor in the regression analyses. Scores were computed by summing the responses, with missing responses (up to 3 items) imputed using the mean of the completed items; scores with fewer than 7 completed items were considered invalid [33]. The possible range of the total sum score is 0–40, with higher scores reflecting higher levels of resilience. Internal consistency of the CD-RISC 10 in the present sample was good (Cronbach's α = 0.85).
Sociodemographic and cancer-related characteristics
Sociodemographic characteristics, including the survivors’ age at study (assessed continuously and categorized into 21–30, 31–39, ≥ 40 years), gender (female, male, diverse), highest educational achievement (compulsory schooling, vocational training, upper secondary education, university degree), employment status (full-time employed, part-time employed, homeworker, unemployed), partnership status (yes, no), and migration background (yes, no; survivors were classified as having a migration background if they were not Swiss citizens, not Swiss citizens since birth or were not born in Switzerland), were assessed in the questionnaire. For further analysis, we categorized the highest educational achievement into low (compulsory schooling, vocational training) and high (upper secondary education, university education), and employment status into employed (full-time, part-time) and other situations (homeworker, unemployed).
We assessed information on diagnosis (classified according to the AYA cancer classification by Barr et al. [34]; leukemias and related disorders, lymphomas, CNS and other intracranial and intraspinal neoplasms, sarcomas, blood and lymphatic vessel tumors, nerve sheath tumors, gonadal and related tumors, melanoma malignant, carcinomas). For further analysis, we categorized information on diagnosis into carcinomas, gonadal tumors, lymphomas, and other tumors (leukemias, CNS neoplasms, sarcomas, nerve sheath tumors, and malignant melanoma). We assessed information on age at diagnosis (assessed continuously and categorized into 21–30, 31–39 years), time since diagnosis (assessed continuously and categorized into 2–5, 6–9, 10–13 years), and treatment (hierarchically coded as surgery only, chemotherapy (may have had surgery), radiotherapy (may have had surgery and/or chemotherapy)), stem cell transplantation (may have had surgery and/or chemotherapy and /or radiotherapy). For further analysis, we categorized treatment hierarchically into surgery (surgery only), chemotherapy (may have had surgery), and radiotherapy and stem cell transplantation (may have had surgery and/or chemotherapy). We asked survivors whether they had experienced any late effects, cancer relapses, or second malignancies (yes, no). For n = 103 survivors, cancer-related data from the corresponding cancer registry were available.
Statistical analysis
We performed all statistical analyses using Stata 19.0 (StataCorp, TX). First, descriptive statistics were calculated for sociodemographic and cancer-related characteristics to describe the study population. We compared our YACS sample with the corresponding YACS population in Switzerland. Where cancer-related data from the questionnaire was missing (diagnosis: n = 2, year of diagnosis: n = 4, treatment: n = 3, relapse: n = 3, second cancer: n = 3), information was imputed using the cancer-related data from the cancer registries, where available. Additionally, we checked and validated the cancer-related data from the questionnaire for the survivors where we had data from the registry available and added information from the registry if the answer from the questionnaire was not complete (treatment: n = 19; no other disagreements). We used descriptive statistics and calculated chi-square tests for categorical variables to compare our YACS sample with the corresponding YACS population in Switzerland. P values < 0.05 were considered statistically significant if not stated otherwise.
For aim 1, we used descriptive statistics to describe PTG and resilience. We had to exclude n = 3 participants from the respective analysis as more than half of the items within one domain of the PTGI were missing. Regarding resilience, we replaced missing responses with the mean of the completed items if at least 7 items were completed (n = 4) and scores with fewer than 7 completed items were considered invalid (n = 3).
For aim 2, we ran univariable and multivariable linear regression analyses to investigate the associations of PTG with resilience, sociodemographic, and cancer-related characteristics. All variables that were statistically significant at p < 0.1 in the univariable model were included in the multivariable model. P-values for categorical independent variables with more than two levels were calculated using the Wald test. For the multivariable models, normality of residuals and homoscedasticity were assessed and considered adequately met. Additionally, we conducted an explorative analysis of the associations of the resilience items with the PTG sum score which was motivated by the possibility that associations between specific resilience components and PTG might be masked when only the aggregated CD-RISC 10 sum score is considered. We further examined associations of the different characteristics assessed with the five PTGI domains, similarly motivated by the possibility of domain-specific effects masked by the global PTG score.
Results
Sample characteristics
We contacted 678 YACS and received 236 responses (34.8%). Of these, 175 (25.8%) were positive responses (e.g., we received either informed consent or the questionnaire), and 131 participants (19.3%) could be included in our analysis (Supplementary Information, Figure S1). The study population and the YACS population of Switzerland were similar regarding gender and age at diagnosis, but not regarding diagnosis, treatment, and second cancer (Supplementary Information, Table S1). The study sample included more gonadal tumors (24% vs. 16%) and fewer lymphomas (18% vs. 11%) and melanomas (8% vs. 14%), and more survivors treated with chemotherapy (33% vs. 16%), radiotherapy (37% vs. 21%), and stem cell transplantation (7% vs. 1%), and more with a second cancer (7% vs. 2%).
Participating survivors had a mean age at study of 37.6 years (SD = 5.1, Table 1), and 81 (61.8%) of them were females. Most survivors had completed upper secondary education (n = 53, 40.5%) and were employed full-time (n = 56, 42.8%). Main diagnoses were carcinomas (n = 52, 39.7%), gonadal tumors (n = 31, 23.7%) and lymphomas (n = 23, 17.5%).
Table 1Sociodemographic and cancer-related characteristics of study participants
Survivors of young adult cancer (n = 131)
n (%) %
Sociodemographic characteristics
Gender
Female 81 61.8
Male 50 38.2
Age at study
21–30 years 13 9.9
31–39 years 71 54.2
40–44 years 39 29.8
45–49 years 5 3.8
≥ 50 years 3 2.3
Migration background
No 126 96.2
Yes 5 3.8
Educational achievement
Compulsory schooling 2 1.5
Vocational training 48 36.6
Upper secondary education 53 40.5
University education 28 21.4
Employment status at study
Employed full-time 56 42.8
Employed part-time 34 25.9
Homeworker 27 20.6
Not employed 14 10.7
Partnership at study
Yes 102 77.9
No 29 22.1
Cancer-related characteristics
Diagnosis (Barr et al. 2020)a
Carcinomas 52 39.7
Breast cancer 33 25.2
Colorectal or anal cancer 12 9.1
Thyroid cancer 5 3.8
Pancreatic cancer 1 0.8
Bladder cancer 1 0.8
Gonadal tumors 31 23.7
Lymphomas 23 17.5
Other tumorsb 25 19.1
Treatmentc
Surgery 30 22.9
Chemotherapy 43 32.8
Radiotherapy 49 37.4
Stem cell transplantation 9 6.9
Age at diagnosis
21–30 years 50 38.2
31–39 years 81 61.8
Time since diagnosis
2–5 years 56 42.8
6–9 years 56 42.8
10–13 years 19 14.4
Late effects
No 86 65.7
Yes 45 34.3
Relapse
No 119 90.8
Yes 12 9.2
Second cancer
No 122 93.1
Yes 9 6.9
Mean SD Range
Age at study (in years) 37.6 5.12 25–52
Age at diagnosis (in years) 31.3 5.04 21–40
Time since diagnosis (in years) 6.3 2.76 2–13
Abbreviations: CNS central nervous system, n = number, SD standard deviation
a Cancer categories according to the cancer classification by Barr et al. [34]
b The category “other tumors” consists of leukemias, CNS neoplasms, sarcomas, nerve sheath tumors, and malignant melanoma
c Hierarchically coded: chemotherapy may include surgery, radiotherapy may include surgery and/or chemotherapy, stem cell transplantation may include surgery and/or chemotherapy and/or radiotherapy
Posttraumatic growth
The mean PTG sum score was 54.6 (SD = 23.0, range: 1–101), and the mean PTG mean score was 2.5 (SD = 1.1, range: 1–5). YACS reported most PTG in Appreciation of life and least in Spiritual change (Fig. 1).
The four most endorsed items were from Appreciation of life: “My priorities about what is important in life” and “An appreciation for the value of my own in life”, from Relating to others: “Knowing that I can count on people” and from Personal strengths: “Knowing that I can handle difficulties” (Supplementary Information, Figure S2). The three least endorsed items were from Spiritual change: “A better understanding of spiritual matters” and “I have stronger religious faith”, and from New possibilities: “New opportunities are available which wouldn’t have been otherwise”.
Resilience
The mean resilience score was 28.1 (SD = 5.9, range: 10–39). YACS reported the highest resilience scores within the item “You can achieve your goals” and least within the item “See humorous side of things” (Fig. 2).
The three most endorsed items of the CD-RISC 10 were: “You can achieve your goals”, “Adapt to change”, and “Tend to bounce back after illness or hardship”. The three least endorsed items were: “Coping with stress strengthens”, “Not easily discouraged by failure”, and “See humorous side of things” (Supplementary Information, Figure S3).
Associations of PTG with sociodemographic and cancer-related characteristics, and resilience
Table 2 shows the univariable and multivariable linear regressions investigating the associations of sociodemographic and cancer-related characteristics and resilience with PTG (PTG sum score). Female sex was significantly associated with higher PTG scores compared to male sex (10.08; p = 0.038). Regarding treatment, participants who had received chemotherapy showed significantly higher PTG scores than those who had undergone surgery only (15.62; overall p = 0.014).
Table 2Univariable and multivariable linear regressions investigating the associations of sociodemographic and cancer-related characteristics, and resilience with PTG (PTG sum score)
Univariable linear regression Multivariable linear regression
Coeff 95% CI p value Coeff 95% CI p valuee
Sociodemographic characteristics
Sex 0.001 0.038
Male Ref Ref
Female 13.59 5.71—21.45 10.08 0.06—19.56
Age at study 0.705
21–30 years Ref
> = 31 2.16 −11.19—15.51
Migration background 0.383
No Ref
Yes −9.19 −29.96—11.59
Educational achievementa 0.945
Low Ref
High −0.29 −8.51—7.93
Employment statusb 0.553
Employed Ref
Other situation 2.62 −6.10—11.34
Partnership 0.161
No −6.80 −16.35—2.74
Yes Ref
Cancer-related characteristics
Diagnosis 0.010 0.356
Carcinomas Ref Ref
Gonadal tumors −14.29 −24.29—−4.29 −7.49 −19.68—4.69
Lymphomas 4.89 −6.13—15.92 3.44 −7.50—14.38
Other tumorsc −2.68 −13.40—8.04 1.99 −8.75—12.74
Treatmentd 0.009 0.014
Surgery Ref Ref
Chemotherapy 16.27 5.76—26.79 15.62 5.03—26.22
Radiotherapy and stem cell transplantation 12.44 2.50—22.38 7.31 −2.89—17.50
Age at diagnosis 0.591
21–30 years Ref
31–39 years 2.23 −5.98—10.44
Time since diagnosis 0.152
2–5 years Ref
6–13 years 5.83 −2.17—13.83
Late effects 0.604
No Ref
Yes 2.21 −6.19—10.61
Relapse 0.325
No Ref
Yes 6.89 −6.04—20.67
Second cancer
No
Yes
Ref
5.36
−10.4—21.12 0.502
CD-RISC 10
Resilience sum score 0.28 −0.39—0.96 0.408
*CI confidence interval, Coeff. coefficient, Ref. reference category
Bold font indicates statistically significant results
a Educational achievement: low includes compulsory schooling and vocational training; high includes upper secondary education and university education
b Employment status at study: Employed includes full-time and part-time employment. Other situations included homeworkers and those not employed
c The category “other tumors” consists of leukemias, CNS neoplasms, sarcomas, nerve sheath tumors, and malignant melanoma
d Treatment was coded hierarchically as “surgery only”; “chemotherapy (may have had surgery)”; radiotherapy and stem cell transplantation (may have had surgery and/or chemotherapy)”
e P values for categorical independent variables with multiple levels were calculated using the Wald test
In our explorative analysis on the resilience items, the items Adapt to change (p = 0.035) and See humorous side of things (p = 0.029) were statistically significantly associated with the PTG sum score (Supplementary Information, Table S5). In our explorative analyses on the five PTG domains, results were similar as for the PTG sum score with some more assessed characteristics significantly associated with some of the PTG domains (Supplementary Information, Tables S3 to S7). Higher resilience was significantly associated with higher PTG in the domain Personal strength.
Discussion
In our study, we found that Swiss YACS reported middle to high levels of PTG and resilience. Female survivors and those who had received chemotherapy reported higher PTG. Resilience was not associated with PTG.
(A)YAs with cancer are diagnosed during a unique period of their life, full of psychosocial changes. The moderate PTG levels of our YACS sample are comparable to a recent Swiss study, reporting moderate PTG levels in Swiss AYA cancer survivors [20]. A systematic review in AYA cancer patients reported generally moderate resilience levels, similar to ours [17]. The YACS in our sample were diagnosed during young adulthood (21 to 39 years of age) and on average aged 38 years (SD = 5 years) at time of assessment. Our results therefore add to the literature on positive outcomes in people being diagnosed in the AYA age range.
Female participants reported significantly higher PTG compared to males. There are mixed results in the literature regarding sex and the development of PTG [15, 20, 35, 36]. One possible explanation of our finding might be that women may be more likely than men to engage in emotional disclosure and receive social support, which have been linked to increased PTG [37]. Our exploratory analyses on the PTG domains showed this sex difference as well as the association with cancer treatment for some PTG domains as well. This pattern parallels findings in breast cancer survivors, where domain-level associations largely mirrored those for the global PTG score [38]. A similar distinction between broad, general effects and domain-specific effects on PTG has also been described in childhood cancer survivors [39].
In line with previous studies showing that receiving chemotherapy or experiencing unexpected complications during treatment was associated with higher levels of PTG, our study also found that YACS who underwent chemotherapy reported significantly higher levels of PTG than those treated with surgery only [35, 40, 41]. This finding aligns with the theoretical assumption that more threatening or life-disrupting experiences may trigger stronger PTG responses by encouraging deeper cognitive engagement and emotional processing [23]. Accordingly, the longer duration of chemotherapy may offer more opportunity for such processing, thereby facilitating PTG. Supporting this, Danhauer et al. (2015) found that breast cancer survivors who reported higher levels of PTG were more likely to have received chemotherapy compared to those with very low PTG [38]. Similarly, a recent study showed that breast cancer patients perceived chemotherapy as more emotionally burdensome and threatening than surgery, which may increase the potential for trauma-related reappraisal and growth [42].
There are differing findings on the relationship between resilience and PTG across different populations (e.g., cancer patients and survivors, persons after childhood abuse) [43, 44], and our results contribute to this complexity. Most studies found that there is a positive relationship between resilience and PTG, meaning that a more resilient individual also reported a higher level of PTG [27, 45]. For instance, a recent study among female patients with breast cancer found that resilience was only positively associated with PTG in patients who considered cancer as a traumatic experience [28]. As we did not assess perceived trauma, this may partly explain the flattened resilience–PTG association observed. It is conceivable, though speculative, that survivors who perceived their cancer as more traumatic might show a stronger resilience–PTG association. Another study identified a curvilinear relationship between resilience and PTG, whereby moderate levels of resilience were associated with the highest PTG levels, suggesting that low resilience may result in emotional overwhelm, while high resilience might limit the cognitive and emotional processing required for growth [46]. Furthermore, Seiler et al. (2019) suggested that the relationship between resilience and PTG may follow distinct temporal trajectories along the cancer continuum, with resilience playing a more prominent role during the acute treatment phase, while PTG tends to emerge later, particularly during long-term survivorship [47]. This may also help explain the lack of significant association found in our survivor sample, even though resilience as a whole was moderate to high, as were reported levels of PTG. The absence of an association at the global resilience level may also reflect limited statistical power in our sample. Another explanation may lie in the theoretical distinction between resilience and PTG. While resilience often reflects a return to baseline functioning after adversity, like a bounce back, PTG involves deeper cognitive transformation and meaning reconstruction through struggle [23, 47]. Even though they are both salutogenic constructs, this may lead to different pathways of adaptation [43, 48]. Additionally, a study including AYA cancer patients showed that resilience was positively correlated with quality of life and life satisfaction, but did not consistently predict the development of PTG [17].
Resilience is a multifaceted construct, indicating that some but not all components of resilience may be associated with PTG. In our exploratory analysis, the humor-related item “See humorous side of things” from the resilience scale was positively associated with PTG, despite its overall low endorsement in our YACS sample. This supports previous findings that cognitive reappraisal strategies, including humor, can promote PTG by facilitating emotional regulation, maintaining perspective, and fostering meaning-making [49].
The non-association of PTG and resilience in our study could reflect both theoretical and measurement complexities: standard resilience measures may not capture the dimensions associated with PTG, and the timing of assessment (cross-sectional versus longitudinal) may obscure dynamic relationships.
Strengths and limitations
A major strength of our study among YACS is the use of internationally established and psychometrically validated instruments, the PTGI for posttraumatic growth and the CD-RISC 10 for resilience, ensuring both methodological rigor and comparability with international research. Moreover, the study benefited from collaboration with four different Swiss clinics, which facilitated participant recruitment.
Besides the strengths of the study, several limitations should be acknowledged. Firstly, the sample size was relatively small and limited to German-speaking participants, which may reduce the generalizability of findings for other language regions within Switzerland or other countries. Despite the similarity of our sample to the Swiss YACS population regarding gender and age at diagnosis, substantial differences in diagnosis, treatment, and second cancer history may affect the transferability of our results to the broader Swiss survivor population. Although the inclusion of four clinics facilitated recruitment, the number of participating institutions remained limited due to legal and organizational hurdles, which restricted broader outreach and may have introduced selection bias. Additionally, as the AYA age range spans distinct developmental stages [50], and about 60% of our study participants were 31 years or older at diagnosis, our findings may reflect this adulthood subgroup more strongly than AYAs being younger at diagnosis. Secondly, comparison between responders and non-responders was not possible, as former patients were contacted directly by the clinics, and data protection regulations prohibited us from accessing their identities prior to receiving written informed consent. This raises the possibility of selection bias, as we cannot rule out that survivors with less PTG were less inclined to participate, though other factors may also explain non-response. Notably, item-level missingness on the PTGI among respondents was low (n = 3 of 131). Thirdly, the cross-sectional design of our study limits conclusions regarding the directionality or causality of the observed associations. Relatedly, we modeled resilience as a predictor rather than a moderator of PTG, testing moderation would require a larger sample than available in our study. Fourthly, although the literature has established cancer as a potentially traumatic experience [14], our questionnaire did not assess whether participants subjectively perceived their own cancer as traumatic, which limits the interpretation of PTG scores. Finally, several analytical choices should be noted: categorization cut-offs followed previous publications rather than our sample's empirical distribution and our primary regression models focused on the PTG sum score, although we additionally conducted exploratory analyses examining the five PTGI domains; these exploratory item-level and domain-level analyses were not adjusted for multiple comparisons and should therefore be interpreted with caution. Our broader survey also covered topics such as family, friends, and psychosocial support, which were not analyzed here but may warrant dedicated attention in future work.
Clinical implications
Based on our findings, several clinical implications emerge that may help inform supportive care practices for YACS.
Tailor psychosocial support to different adaptive pathways: Our findings suggest that resilience and PTG represent distinct processes. Psychosocial programs should therefore differentiate between recovery-focused and growth-oriented support. For example, resilience training might focus on strengthening stable coping capacities, while PTG interventions could encourage deeper reflection and meaning-making [48].This distinction is supported by intervention research: randomized controlled trials of resilience-promoting interventions in cancer patients have primarily targeted the restoration and strengthening of coping resources [51], whereas meaning-centered group psychotherapy, focused on personal meaning-making, has shown specific effects on posttraumatic growth [52].
Recognize the individual variation in PTG experiences: Given the wide range of PTG levels in our sample, psychosocial care should acknowledge that not all YACS experience the same levels of PTG. Some cancer patients or survivors may perceive growth, while others might feel pressured to report positive changes or experience illusory growth [53, 54]. Furthermore, our finding that female participants reported higher PTG than males highlights the need to consider gender-specific experiences and coping styles in post-cancer care. Thus, professionals should avoid assuming universal PTG and instead adopt a sensitive, individualized approach that validates both positive and negative post-cancer experiences.
Address the emotional impact of intensive treatments such as chemotherapy: Survivorship care should provide space for reflection and guided processing for those who underwent intensive treatments, acknowledging both the psychological burden and potential for positive change.
Together, these implications emphasize the importance of nuanced, individualized psychosocial care that recognizes the diverse ways young adult cancer survivors respond to their experiences, whether through resilience, PTG, or both, and supports them accordingly across the survivorship trajectory. This may include subtle, low-threshold support formats (e.g., poster, flyer) to respect individual readiness and preferences.
Conclusion
In our study, Swiss YACS reported middle to high levels of PTG and resilience. PTG was higher among females and those who received chemotherapy, while resilience showed no significant association with PTG. These findings support the hypothesis that PTG and resilience are distinct adaptation processes. While resilience may reflect returning to baseline functioning, PTG may involve deeper psychological change. Tailoring support to individual experiences can help YACS navigate the complex psychological aftermath of cancer more effectively.
Supplementary Information
Below is the link to the electronic supplementary material.
Acknowledgements
We thank Angela Pfister for her support within the Psychosocial Health Study and Dr. Daniela Dyntar for her expertise and contributions to the conceptualization of the study. We are grateful to Kantonsspital Luzern, Kantonsspital Baselland, Kantonsspital Olten, and Bürgerspital Solothurn for their collaboration for the participant recruitment. We also thank Registro Cantonale dei Tumori, Krebsregister Ostschweiz, Krebsregister Bern Solothurn, Krebsregister der Kantone Zürich, Zug, Schaffhausen und Schwyz, Zentralschweizer Krebsregister, Krebsregister beider Basel, Krebsregister Graubünden-Glarus, and Stiftung Krebsregister Aargau for their support for clinic recruitment and the provision of cancer-related data. Finally, we sincerely thank all participating survivors for their time and valuable contribution to this study.
Abbreviations
AYAsAdolescent and young adults
CI Confidence interval
CNSCentral nervous system
OROdds ratio
RefReference category
N, nNumber
YACSYoung adult cancer survivors
Authors' contributions
Conceptualization and design of the work: Katharina Roser. Methodology: Katharina Roser and Céline Bolliger. Formal analysis: Céline Bolliger. Investigation: Beat Müller, Marcus Vetter, and Katharina Roser. Resources: Luzius Mader, Mohsen Mousavi, Marcel Blum and Katharina Roser. Data curation: Céline Bolliger and Katharina Roser. Writing original draft preparation: Céline Bolliger. Writing review and editing: all authors. Visualization: Céline Bolliger. Supervision: Katharina Roser. Project administration: Céline Bolliger and Katharina Roser. Funding acquisition: Katharina Roser.
Funding
Open access funding provided by University of Luzern. Palatin-Stiftung Switzerland (Nr. 0028/2020), Krebsliga Zentralschweiz Switzerland, and Avenira Stiftung Switzerland.
Data availability
The data that support the findings of this study are available from the corresponding author upon reasonable request.
Code availability
Not applicable.
Declarations
Ethics approval
All procedures performed in this study were in accordance with the ethical standards of the responsible research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The study was approved by the Ethics Committee Northwest and Central Switzerland (EKNZ 2022–01065, 12 October 2022).
Consent to participate
Written informed consent was obtained on paper from all individual participants included in the study.
Conflicts of interest
The authors declare no conflict of interest.
Footnotes
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
References
1.Stark D, Bielack S, Brugieres L, Dirksen U, Duarte X, Dunn S et al (2015) Teenagers and young adults with cancer in Europe: from national programmes to a European integrated coordinated project. Eur J Cancer Care 25(3):419–427. 10.1111/ecc.12365
2.Bleyer A, Ferrari A, Whelan J, Barr RD (2017) Global assessment of cancer incidence and survival in adolescents and young adults. Pediatr Blood Cancer. 10.1002/pbc.26497
3.Fidler MM, Gupta S, Soerjomataram I, Ferlay J, Steliarova-Foucher E, Bray F (2017) Cancer incidence and mortality among young adults aged 20–39 years worldwide in 2012: a population-based study. Lancet Oncol 18(12):1579–1589. 10.1016/S1470-2045(17)30677-0
4.Tricoli JV, Bleyer A (2018) Adolescent and young adult cancer biology. Cancer J Sudbury Mass 24(6):267–274. 10.1097/PPO.0000000000000343
5.Desandes E, Stark DP (2016) Epidemiology of adolescents and young adults with cancer in Europe. Tumors Adolesc Young Adults 43:1–15. 10.1159/000447037
6.Birch JM, Bleyer A (2007) Epidemiology and etiology of cancer in adolescents and young adults. In: Bleyer WA, Barr RD (eds) Cancer in Adolescents and Young Adults. Berlin, Heidelberg, Springer Berlin Heidelberg, pp 39–59. (Pediatric Oncology). 10.1007/978-3-540-68152-6_3
7.Ferrari A, Thomas D, Franklin ARK, Hayes-Lattin BM, Mascarin M, Van Der Graaf W et al (2010) Starting an adolescent and young adult program: some success stories and some obstacles to overcome. J Clin Oncol 28(32):4850–4857. 10.1200/JCO.2009.23.8097
8.Saloustros E, Stark DP, Michailidou K, Mountzios G, Brugieres L, Peccatori FA et al (2017) The care of adolescents and young adults with cancer: results of the ESMO/SIOPE survey. ESMO Open 2(4):e000252. 10.1136/esmoopen-2017-000252
9.Ryder-Burbidge C, Diaz RL, Barr RD, Gupta S, Nathan PC, McKillop SJ et al (2021) The burden of late effects and related risk factors in adolescent and young adult cancer survivors: a scoping review. Cancers. 10.3390/cancers13194870
10.Michel G, François C, Harju E, Dehler S, Roser K (2019) The long-term impact of cancer: evaluating psychological distress in adolescent and young adult cancer survivors in Switzerland. Psychooncology 28(3):577–585. 10.1002/pon.4981
11.Galán S, de la Vega R, Miró J (2018) Needs of adolescents and young adults after cancer treatment: a systematic review. Eur J Cancer Care (Engl) 27(6):e12558. 10.1111/ecc.12558
12.Altherr A, Bolliger C, Kaufmann M, Dyntar D, Scheinemann K, Michel G et al (2023) Education, employment, and financial outcomes in adolescent and young adult cancer survivors-a systematic review. Curr Oncol 30(10):8720–8762. 10.3390/curroncol30100631
13.Bradford NK, McDonald FEJ, Bibby H, Kok C, Patterson P (2022) Psychological, functional and social outcomes in adolescent and young adult cancer survivors over time: A systematic review of longitudinal studies. Psychooncology 31(9):1448–1458. 10.1002/pon.5987
14.Cordova MJ, Riba MB, Spiegel D (2017) Post-traumatic stress disorder and cancer. Lancet Psychiatry 4(4):330–338. 10.1016/S2215-0366(17)30014-7
15.Love C, Sabiston CM (2011) Exploring the links between physical activity and posttraumatic growth in young adult cancer survivors. Psychooncology 20(3):278–286. 10.1002/pon.1733
16.Gianinazzi ME, Rueegg CS, Vetsch J, Luer S, Kuehni CE, Michel G, Swiss Pediatric Oncology Group (SPOG) (2015) Cancer’s positive flip side: posttraumatic growth after childhood cancer. Support Care Cancer 24(1):195–203. 10.1007/s00520-015-2746-1
17.Greup SR, Kaal SEJ, Jansen R, Manten-Horst E, Thong MSY, van der Graaf WTA et al (2018) Post-traumatic growth and resilience in adolescent and young adult cancer patients: an overview. J Adolesc Young Adult Oncol 7(1):1–14. 10.1089/jayao.2017.0040
18.Tedeschi RG, Calhoun LG (2004) TARGET ARTICLE: “Posttraumatic Growth: Conceptual Foundations and Empirical Evidence.” Psychol Inq 15(1):1–18. 10.1207/s15327965pli1501_01
19.Tedeschi RG, Park CL, Calhoun LG (eds) (1998) Posttraumatic growth: positive changes in the aftermath of crisis. Routledge, New York, p 267. 10.4324/9781410603401
20.Bolliger C, Holmer P, Dehler S, Roser K, Michel G (2023) Posttraumatic growth and illness perception in survivors of adolescent and young adult cancer. Discov Oncol 14(1):194. 10.1007/s12672-023-00810-3
21.VandenBos GR (ed) (2015) APA dictionary of psychology, 2nd ed. American Psychological Association, Washington. 10.1037/14646-000
22.Elam T, Taku K (2022) Differences between posttraumatic growth and resiliency: their distinctive relationships with empathy and emotion recognition ability. Front Psychol 28(13):825161. 10.3389/fpsyg.2022.825161
23.Tedeschi RG, Calhoun LG, Cann A (2007) Evaluating resource gain: understanding and misunderstanding posttraumatic growth. Appl Psychol 56(3):396–406. 10.1111/j.1464-0597.2007.00299.x
24.Westphal M, Bonanno GA (2007) Posttraumatic growth and resilience to trauma: different sides of the same coin or different coins? Appl Psychol 56(3):417–427. 10.1111/j.1464-0597.2007.00298.x
25.Hebel K, Jałtuszewska S, Steliga A, Kłosiewicz T, Ślęzak D, Głowiński S (2025) Resilience as a personality trait and stress coping styles: a cross-sectional analysis of a paramedic student cohort. J Clin Med 14(6):6. 10.3390/jcm14061878
26.Tedeschi RG, Calhoun LG (1996) The posttraumatic growth inventory: measuring the positive legacy of trauma. J Trauma Stress 9(3):455–471. 10.1002/jts.2490090305
27.Bensimon M (2012) Elaboration on the association between trauma, PTSD and posttraumatic growth: the role of trait resilience. Personal Individ Differ 52(7):782–787. 10.1016/j.paid.2012.01.011
28.Gundogmus AG, Katar KS, Orsel S, Ozturk G, Yilmaz KB (2022) The relationship of potential biomarkers with psychological resilience and post-traumatic growth in female patients with breast cancer. PLoS ONE 17(12):e0277119. 10.1371/journal.pone.0277119
29.Duran S, Varol U, Tekir Ö, Soytürk AH (2024) Resilience’s impact on quality of life and post-traumatic growth in breast cancer patients during treatment. Breast Cancer (Auckl) 31(5):807–814. 10.1007/s12282-024-01594-2
30.Atay Turan S, Sarvan S, Akcan A, Guler E, Say B (2023) Adolescent and young adult survivors of cancer: relationship between resilience and post-traumatic growth. Curr Psychol 42(29):25870–25879. 10.1007/s12144-022-03649-z
31.Kuehni CE, Rueegg CS, Michel G, Rebholz CE, Strippoli MPF, Niggli FK et al (2012) Cohort profile: the Swiss childhood cancer survivor study. Int J Epidemiol 41(6):1553–1564. 10.1093/ije/dyr142
32.Connor KM, Davidson JRT (2003) Development of a new resilience scale: the connor-davidson resilience scale (CD-RISC). Depress Anxiety 18(2):76–82. 10.1002/da.10113
33.CD-RISC: About [Internet]. [cited 2025 Jul 8]. Available from: https://www.connordavidson-resiliencescale.com/faq.php. Accessed 8 Jul 2025
34.Barr RD, Ries LAG, Trama A, Gatta G, Steliarova‐Foucher E, Stiller CA et al (2020) A system for classifying cancers diagnosed in adolescents and young adults. Cancer 126(21):4634–4659. 10.1002/cncr.33041
35.McDonnell GA, Pope AW, Schuler TA, Ford JS (2018) The relationship between cancer-related worry and posttraumatic growth in adolescent and young adult cancer survivors. Psychooncology 27(9):2155–2164. 10.1002/pon.4785
36.Barrett-Bernstein M, Wurz A, Brunet J (2020) Posttraumatic growth and its correlates among survivors of adolescent and young adult cancer: a brief report. J Psychosoc Oncol 38(2):228–234. 10.1080/07347332.2019.1664702
37.Vishnevsky T, Cann A, Calhoun LG, Tedeschi RG, Demakis GJ (2010) Gender differences in self-reported posttraumatic growth: a meta-analysis. Psychol Women Q 34(1):110–120. 10.1111/j.1471-6402.2009.01546.x
38.Danhauer SC, Russell G, Case LD, Sohl SJ, Tedeschi RG, Addington EL et al (2015) Trajectories of posttraumatic growth and associated characteristics in women with breast cancer. Ann Behav Med 49(5):650–659. 10.1007/s12160-015-9696-1
39.Laceulle OM, Kleber RJ, Alisic E (2015) Children’s experience of posttraumatic growth: distinguishing general from domain-specific correlates. PLoS ONE 10(12):e0145736. 10.1371/journal.pone.0145736
40.Park CL, Cho D (2017) Spiritual well-being and spiritual distress predict adjustment in adolescent and young adult cancer survivors. Psychooncology 26(9):1293–1300. 10.1002/pon.4145
41.Gunst DCM, Kaatsch P, Goldbeck L (2016) Seeing the good in the bad: which factors are associated with posttraumatic growth in long-term survivors of adolescent cancer? Support Care Cancer 24(11):4607–4615. 10.1007/s00520-016-3303-2
42.Huang S, Huang M, Long F, Wang F (2025) Post-traumatic growth experience of breast cancer patients: A qualitative systematic review and meta-synthesis. PLoS ONE 20(1):e0316108. 10.1371/journal.pone.0316108
43.Levine SZ, Laufer A, Stein E, Hamama-Raz Y, Solomon Z (2009) Examining the relationship between resilience and posttraumatic growth. J Trauma Stress 22(4):282–286. 10.1002/jts.20409
44.Widyorini E, Roswita MY, Primastuti E, Wijaya DA (n.d.) The role of resilience towards the correlation between adverse childhood experiences and post-traumatic growth [Internet]. 10.2174/18743501-v15-e2203280
45.Duan W, Guo P, Gan P (2015) Relationships among trait resilience, virtues, post-traumatic stress disorder, and post-traumatic growth. PLoS ONE 10(5):e0125707. 10.1371/journal.pone.0125707
46.Kaye-Tzadok A, Davidson-Arad B (2016) Posttraumatic growth among women survivors of childhood sexual abuse: its relation to cognitive strategies, posttraumatic symptoms, and resilience. Psychol Trauma Theory Res Pract Policy 8(5):550–558. 10.1037/tra0000103
47.Seiler A, Jenewein J (2019) Resilience in cancer patients. Front Psychiatry 5:10. 10.3389/fpsyt.2019.00208
48.Infurna FJ, Jayawickreme E (2019) Fixing the growth illusion: new directions for research in resilience and posttraumatic growth. Curr Dir Psychol Sci 28(2):152–158. 10.1177/0963721419827017
49.Sierra-Murguía M, Guevara-Sanginés ML, Navarro-Contreras G, Peralta-Castillo G, Padilla-Rico A, González-Alcocer L et al (2024) Relationship between thought style, emotional response, post-traumatic growth (PTG), and biomarkers in cancer patients. Int J Environ Res Public Health. 10.3390/ijerph21060763
50.(2011) What should the age range be for AYA oncology? J Adolesc Young Adult Oncol 1(1):3–10. 10.1089/jayao.2011.1505
51.Ludolph P, Kunzler AM, Stoffers-Winterling J, Helmreich I, Lieb K (2019) Interventions to promote resilience in cancer patients. Dtsch Arzteblatt Int 51–52(51–52):865–872. 10.3238/arztebl.2019.0865
52.van der Spek N, Vos J, van Uden-Kraan CF, Breitbart W, Cuijpers P, Holtmaat K et al (2017) Efficacy of meaning-centered group psychotherapy for cancer survivors: a randomized controlled trial. Psychol Med 47(11):1990–2001. 10.1017/S0033291717000447
53.Matsui T, Taku K (2016) A review of posttraumatic growth and help-seeking behavior in cancer survivors: effects of distal and proximate culture. Jpn Psychol Res 58(1):142–162. 10.1111/jpr.12105
54.Sumalla EC, Ochoa C, Blanco I (2009) Posttraumatic growth in cancer: reality or illusion? Clin Psychol Rev 29(1):24–33. 10.1016/j.cpr.2008.09.006
Associated Data
Supplementary Materials
Data Availability Statement
The data that support the findings of this study are available from the corresponding author upon reasonable request.
Not applicable.
Come citare questo studio
Bolliger C, Mader L, Mousavi M, Blum M, Müller B, Vetter M, Roser K. (2026). Posttraumatic growth and resilience among survivors of cancer in young adulthood in Switzerland: a report from the Adolescent and Young Adult (AYA) Psychosocial Health Study.. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. DOI: 10.1007/s00520-026-11383-6
Consulta la pubblicazione originale ↗